Summary: Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trial.

Summary: Spinocerebellar ataxia 17: full phenotype in a 42 CAG/CAA-repeats carrier.

Summary: Possibilities and challenges of small molecule organic compounds for the treatment of repeat diseases.

Summary: Vocal cord paralysis as a presenting sign of autosomal recessive spinocerebellar atrophy type 10.

Summary: Spinocerebellar ataxia type 28 in a Chinese pedigree: A case report and literature review.

Summary: Proteomic Analysis of Marinesco-Sjogren Syndrome Fibroblasts Indicates Pro-Survival Metabolic Adaptation to SIL1 Loss.

Summary: Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia.

Summary: Cortical and Subcortical Brain Area Atrophy in SCA1 and SCA2 Patients in India: The Structural MRI Underpinnings and Correlative Insight Among the Atrophy and Disease Attributes.

Summary: Nystagmus may be the first neurological sign in early stages of spinocerebellar ataxia type 3.

Summary: Cerebellar degeneration in primary Sjögren syndrome: a case report.

Summary: CRISPR/Cas9 mediated gene correction ameliorates abnormal phenotypes in spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cells.

Summary: Mutations in the Voltage Dependent Calcium Channel CACNA1A (P/Q type alpha 1A subunit) Causing Neurological Disorders - An Overview.